165 related articles for article (PubMed ID: 7589996)
1. [P53 protein: a new tool for the clinician?].
Laurent-Puig P
Gastroenterol Clin Biol; 1995 May; 19(5):463-4. PubMed ID: 7589996
[No Abstract] [Full Text] [Related]
2. p53 and response to chemotherapy and radiotherapy.
Ruley HE
Important Adv Oncol; 1996; ():37-56. PubMed ID: 8791127
[No Abstract] [Full Text] [Related]
3. [Gene therapy of malignant tumors].
Schackert HK; Frost P
Chirurg; 1993 Sep; 64(9):678-83. PubMed ID: 8222924
[No Abstract] [Full Text] [Related]
4. [The p53 gene and protein in 2005: new results, promising opportunities].
Szoke D; Sipos F; Spisák S; Molnár B; Tulassay Z
Orv Hetil; 2005 Jul; 146(30):1587-94. PubMed ID: 16136736
[TBL] [Abstract][Full Text] [Related]
5. [P53 mutations, asset or disadvantage for cancer chemotherapy].
Jacquemin-Sablon A
Bull Cancer; 1997 Jul; 84(7):741-6. PubMed ID: 9339201
[TBL] [Abstract][Full Text] [Related]
6. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.
Smith ND; Rubenstein JN; Eggener SE; Kozlowski JM
J Urol; 2003 Apr; 169(4):1219-28. PubMed ID: 12629332
[TBL] [Abstract][Full Text] [Related]
7. [Expression of phosphoprotein P53 in pathology].
Casazza S
Pathologica; 1993; 85(1097):321-34. PubMed ID: 8233649
[No Abstract] [Full Text] [Related]
8. [The p53 gene and protein in bronchial carcinogenesis:from biological to clinical aspects].
Zalcman G; Trédaniel J; Lechapt E; Lubin R; Soussi T; Hirsch A
Rev Mal Respir; 1994; 11(5):455-72. PubMed ID: 7816989
[TBL] [Abstract][Full Text] [Related]
9. Over-expression of p53 protein in neoplastic changes in ulcerative colitis: immunohistochemical study.
Ajioka Y; Watanabe H; Matsuda K
J Gastroenterol; 1995 Nov; 30 Suppl 8():33-5. PubMed ID: 8563884
[TBL] [Abstract][Full Text] [Related]
10. Changes in protein expression in p53 deleted spontaneous thymic lymphomas.
Honoré B; Vorum H; Pedersen AE; Buus S; Claësson MH
Exp Cell Res; 2004 Apr; 295(1):91-101. PubMed ID: 15051493
[TBL] [Abstract][Full Text] [Related]
11. The p53 tumour suppressor gene and product.
Levine AJ
Cancer Surv; 1992; 12():59-79. PubMed ID: 1638548
[No Abstract] [Full Text] [Related]
12. The p53 tumor suppressor gene as a common cellular target in human carcinogenesis.
Chang F; Syrjänen S; Kurvinen K; Syrjänen K
Am J Gastroenterol; 1993 Feb; 88(2):174-86. PubMed ID: 8424417
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of the tumor suppressor gene p53 and WAF1 gene expression by IP6 in HT-29 human colon carcinoma cell line.
Saied IT; Shamsuddin AM
Anticancer Res; 1998; 18(3A):1479-84. PubMed ID: 9673359
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel enhanced radiation sensitization for the suppression of human prostate cancer tumor growth via a p53 independent pathway.
Zhang AL; Russell PJ; Knittel T; Milross C
Prostate; 2007 Nov; 67(15):1630-40. PubMed ID: 17823933
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of NFkappaB-responsive gene expression by DeltaNp73alpha in p53 null cells.
Tanaka Y; Ota K; Kameoka M; Itaya A; Yoshihara K
Exp Cell Res; 2006 May; 312(8):1254-64. PubMed ID: 16430884
[TBL] [Abstract][Full Text] [Related]
16. The interaction of oncogene and tumour suppressor gene defects with cytotoxic drugs: its role in the improvement of selective toxicity and the development of new drugs in clinical oncology.
Petty RD
Clin Oncol (R Coll Radiol); 1996; 8(3):186-9. PubMed ID: 8814375
[No Abstract] [Full Text] [Related]
17. iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human.
Bergamaschi D; Samuels Y; O'Neil NJ; Trigiante G; Crook T; Hsieh JK; O'Connor DJ; Zhong S; Campargue I; Tomlinson ML; Kuwabara PE; Lu X
Nat Genet; 2003 Feb; 33(2):162-7. PubMed ID: 12524540
[TBL] [Abstract][Full Text] [Related]
18. [Environmental carcinogens and p53 gene mutation].
Xu Z; Jin Y
Wei Sheng Yan Jiu; 2004 Mar; 33(2):239-43. PubMed ID: 15209018
[TBL] [Abstract][Full Text] [Related]
19. [TP53 tumor suppressor gene: 20 years (and ten thousand mutations) later].
Hainaut P
Bull Cancer; 2000 Jan; 87(1):11-8. PubMed ID: 10673626
[No Abstract] [Full Text] [Related]
20. The role of thymidylate synthase induction in modulating p53-regulated gene expression in response to 5-fluorouracil and antifolates.
Longley DB; Boyer J; Allen WL; Latif T; Ferguson PR; Maxwell PJ; McDermott U; Lynch M; Harkin DP; Johnston PG
Cancer Res; 2002 May; 62(9):2644-9. PubMed ID: 11980662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
